Navigation Links
Cedars-Sinai immunotherapy expert honored for work in kidney transplantation
Date:8/7/2014

LOS ANGELES (Aug. 8, 2014) Ashley Anh Vo, PharmD, administrative director of the Transplant Immunotherapy Program at the Comprehensive Transplant Center at Cedars-Sinai, has been named the 2014 Clinician of Distinction by the American Society of Transplantation for her work in developing anti-rejection drug protocols for patients.

"This prestigious award recognizes Dr.Vo's clinical excellence and the creative scholarship she brings to the field of transplantation," said Andrew S. Klein MD, FACS, MBA, director of the Cedars-Sinai Comprehensive Transplant Center. "This is a unique achievement that represents her dedication and tireless work on behalf of transplant patients."

Vo received the award at the recent World Transplant Congress in San Francisco, where Cedars-Sinai kidney transplant clinicians and researchers contributed nearly 30 abstracts and presentations to the international gathering. One of the most highly anticipated presentations involved preliminary research of a new anti-rejection drug known as C1-INH by Stanley C. Jordan, MD, director of kidney transplantation and transplant immunology at Cedars Sinai. Patients in the small trial who received C1-INH after transplantation developed fewer complications.

Vo's research in immunotherapy began in 1994 when she became the transplant pharmacist for Cedars-Sinai and joined a National Institutes of Health investigation headed by Jordan. Since then, Vo and Jordan have collaborated extensively, producing the 2004 landmark study that identified new anti-rejection treatments.

That study tested IVIG, intravenous immunoglobulin, as an effective therapy for lowering a patient's level of HLA antibodies, which can cause a patient's body to reject a transplanted organ. Patients who have been pregnant, been on kidney dialysis or received many blood transfusions often develop HLA antibodies, making it very hard for them to have a successful kidney transplant.

"Dr. Vo has played a key role in our research identifying how IVIG treatment significantly reduces the long amount of time a patient can remain on dialysis, suffering, waiting for a suitable transplant because their HLA antibody levels put them at a high risk of organ rejection," said Jordan. "Her work has been an important asset to the entire field of organ transplantation."


'/>"/>

Contact: Laura Coverson
laura.coverson@cshs.org
310-423-5215
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. California Healthcare Institute Adds Executives from Gilead Sciences, Cedars-Sinai and Versant Ventures to Its Board
2. Cedars-Sinai study identifies heart-specific protein that protects against arrhythmia
3. Cedars-Sinai surgeon and policymaker honored for work in liver disease and transplantation
4. Grant supports Cedars-Sinai study of possible links between air pollution and brain cancer
5. Cedars-Sinai clinical trial studies vaccine targeting cancer stem cells in brain cancers
6. Update: 50 percent of patients in Cedars-Sinai brain cancer study alive after 5 years
7. Prominent Cedars-Sinai medical physicist receives highest honor from distinguished association
8. Cedars-Sinai opens first-of-its-kind trial in western US for metastatic carcinoid cancer patients
9. Heart valve repair innovator receives Cedars-Sinai Heart Institutes Corday Prize in Heart Research
10. Cedars-Sinai study: Obesity may be linked to microorganisms living in the gut
11. Nobel laureate Roger Tsien, Ph.D., keynotes Cedars-Sinai nanomedicine conference March 15, 16
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
Breaking Medicine Technology: